Point of Care Molecular Diagnostics Market Worth $5.38 Billion by 2028 - Exclusive Report by The Insight Partners
October 30, 2023 05:27 ET
|
The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as...
Revolutionizing Molecular Biology: Molecular Grade Plates Market to Witness Exponential Growth and Reach US$ 427.1 million by 2033, Persistence Market Research
May 25, 2023 10:10 ET
|
Persistence Market Research
New York, May 25, 2023 (GLOBE NEWSWIRE) -- The global molecular grade plates market is expected to generate US$ 277.8 million in revenue by the end of 2022, with a CAGR of 4.0% expected to propel...
Point of Care Molecular Diagnostics Market is Expected to Reach $4.1 billion | MarketsandMarkets.
April 24, 2023 09:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 24, 2023 (GLOBE NEWSWIRE) -- The point of care molecular diagnostics industry is expected to grow significantly in the near future. This is due to the increasing adoption of...
Influenza Diagnostics Market Size To Hit US$ 3.1 Billion By 2033, Owing To Increasing Investments in Healthcare Sector Globally | Persistence Market Research
March 23, 2023 22:20 ET
|
Persistence Market Research
New York, March 23, 2023 (GLOBE NEWSWIRE) -- The Influenza Diagnostics Market to reach a valuation of US$ 1.6 Billion in 2022 to US$ 3.1 Billion by the end of 2033, with at a CAGR of 6.1%. ...
Esoteric Testing Market Size & Share | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
November 22, 2022 06:00 ET
|
Graphical Research
Pune, India, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The global esoteric testing market size is predicted to witness remarkable growth during the forecast period, owing to rise in the frequency of rare...
ProPhase Labs Announces Record First Quarter 2022 Financial Results
May 13, 2022 08:30 ET
|
ProPhase Labs, Inc.
Record Net Revenues of $47.5 Million, Up 211% Year-over-Year Record Net Income of $12.5 Million, Increasing 1082% Year-over-Year Announces Special Cash Dividend of $0.30 per...
ProPhase Labs to Present at the Benzinga Healthcare Small Cap Conference
September 22, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Sept. 22, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
January 20, 2021 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US,...
Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel
September 22, 2020 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ AML (Acute Myeloid...
1Drop inc., grâce aux efforts de son distributeur canadien exclusif Luminarie Canada, reçoit l'approbation du 1COPY ™ COVID-19 QPCR KIT en vertu de l'arrêté d’urgence de la Ministre de la Santé
March 31, 2020 19:17 ET
|
Luminarie Canada Inc.
Le 1copy ™ COVID-19 qPCR kit permet l’obtention de résultats en moins de 2 heures. Test hautement sensible: limite de détection de 200 copies de génome par mL, ce qui est équivalent à 4 copies de...